Skip to main content
. 2022 Sep 19;10(5):e01315-22. doi: 10.1128/spectrum.01315-22

FIG 1.

FIG 1

Scatterplot of the full study cohort, demonstrating relationships between live viral neutralizing antibody titers and immunogenicity measures. (A) Anti-spike total antibody concentrations (U/mL), measured on the Elecsys assay. (B) Anti-spike IgG antibody concentrations (AU/mL), measured on the V-PLEX assay. (C) Anti-receptor-binding domain (RBD) IgG antibody concentrations (AU/mL). (D) Anti-N-terminal domain (NTD) IgG antibody concentrations (AU/mL). (E) Inhibition of ACE-2 binding to RBD protein concentrations (U/mL). Ab, antibody.